Colorectal Cancer Molecular Diagnostics Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors

The Business Research Company’s Colorectal Cancer Molecular Diagnostics Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 24, 2024 /EINPresswire.com/ -- Colorectal cancer, a malignant tumor affecting the colon or rectum, is driving the growth of the colorectal cancer molecular diagnostics market. The market is projected to grow from $2.35 billion in 2023 to $2.56 billion in 2024, with a compound annual growth rate (CAGR) of 9.2%.

Drivers of Market Growth
The historic growth of the colorectal cancer molecular diagnostics market can be attributed to factors such as increasing cancer incidence, growing awareness, and personalized medicine initiatives. Additionally, government efforts for cancer control have contributed to market growth.

Explore the global colorectal cancer molecular diagnostics market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=13120&type=smp

Market Outlook
The colorectal cancer molecular diagnostics market is expected to continue its growth trajectory, reaching $3.48 billion by 2028, with a CAGR of 8.0%. Factors such as an aging population, integration of genomic data into clinical practice, and global cancer research efforts are expected to drive market growth.

Rising Prevalence of Colorectal Cancer
The rising prevalence of colorectal cancer, with an estimated 153,020 new cases expected in 2023 according to the American Cancer Society, is driving the demand for molecular diagnostics. Early detection and treatment are crucial for improving outcomes in colorectal cancer patients.

Major Players and Innovations
Leading companies in the colorectal cancer molecular diagnostics market, including Johnson & Johnson and Abbott Laboratories, are focusing on developing innovative molecular diagnostics solutions. For instance, Guardant Health launched the Shield Blood Test, a blood test designed to identify early-stage colorectal cancer.

Regional Insights
North America dominated the colorectal cancer molecular diagnostics market in 2023, with Asia-Pacific expected to be the fastest-growing region. The comprehensive report provides detailed insights into regional dynamics, market trends, and growth opportunities.

Market Segmentation
The colorectal cancer molecular diagnostics market covered in this report is segmented –
1) By Type: Instruments, Reagents And Kits, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings

Access the complete report for an in-depth analysis of the global colorectal cancer molecular diagnostics market:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-molecular-diagnostics-global-market-report

Colorectal Cancer Molecular Diagnostics Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Colorectal Cancer Molecular Diagnostics Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on colorectal cancer molecular diagnostics market size, colorectal cancer molecular diagnostics market drivers and trends, colorectal cancer molecular diagnostics market major players, competitors' revenues, market positioning, and market growth across geographies. The colorectal cancer molecular diagnostics market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Small Cell Lung Cancer Therapeutics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

Urinary Tract Cancer Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urinary-tract-cancer-global-market-report

Blockchain Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn